Using Breast Cancer Risk Associated Polymorphisms to Identify Women for Breast Cancer Chemoprevention

scientific article

Using Breast Cancer Risk Associated Polymorphisms to Identify Women for Breast Cancer Chemoprevention is …
instance of (P31):
scholarly articleQ13442814

External links are
P819ADS bibcode2017PLoSO..1268601Z
P356DOI10.1371/JOURNAL.PONE.0168601
P932PMC publication ID5249071
P698PubMed publication ID28107349

P50authorCeline M. VachonQ74173260
Karla KerlikowskeQ92299671
P2093author name stringElad Ziv
Steven R Cummings
Jeffrey A Tice
Brian Sprague
P2860cites workGenome-wide association studies identify four ER negative-specific breast cancer risk lociQ24622610
Genome-wide association study identifies novel breast cancer susceptibility lociQ24645441
Genome-wide association study identifies a new breast cancer susceptibility locus at 6q25.1.Q37369631
A large-scale assessment of two-way SNP interactions in breast cancer susceptibility using 46,450 cases and 42,461 controls from the breast cancer association consortiumQ37619303
Barriers to the Use of Breast Cancer Risk Reduction TherapiesQ38543497
Breast cancer risk prediction using a clinical risk model and polygenic risk scoreQ40605693
Distribution of breast cancer risk from SNPs and classical risk factors in women of routine screening age in the UK.Q42587251
Exemestane for breast-cancer prevention in postmenopausal women.Q48657440
A breast cancer prediction model incorporating familial and personal risk factors.Q52000310
Projecting individualized probabilities of developing breast cancer for white females who are being examined annuallyQ69396132
The effect of raloxifene on risk of breast cancer in postmenopausal women: results from the MORE randomized trial. Multiple Outcomes of Raloxifene EvaluationQ28137833
Tamoxifen for prevention of breast cancer: report of the National Surgical Adjuvant Breast and Bowel Project P-1 StudyQ28283241
Prevention of breast cancer in postmenopausal women: approaches to estimating and reducing riskQ28390064
Presymptomatic risk assessment for chronic non-communicable diseasesQ28743818
Genome-wide association study in east Asians identifies novel susceptibility loci for breast cancerQ28924377
The Effect of Raloxifene on Risk of Breast Cancer in Postmenopausal WomenQ29396434
Large-scale genotyping identifies 41 new loci associated with breast cancer riskQ29416989
Genome-wide association study identifies a common variant in RAD51B associated with male breast cancer riskQ29417050
Willingness to use tamoxifen to prevent breast cancer among diverse womenQ33688754
Genome-wide association analysis in East Asians identifies breast cancer susceptibility loci at 1q32.1, 5q14.3 and 15q26.1.Q34023796
Performance of common genetic variants in breast-cancer risk modelsQ34064069
Genome-wide association study identifies five new breast cancer susceptibility lociQ34114293
Medications to decrease the risk for breast cancer in women: recommendations from the U.S. Preventive Services Task Force recommendation statement.Q34372923
Genome-wide association study of breast cancer in Latinas identifies novel protective variants on 6q25.Q34375940
Using the optimal robust receiver operating characteristic (ROC) curve for predictive genetic tests.Q34577794
Combined associations of genetic and environmental risk factors: implications for prevention of breast cancerQ34736112
Genome-wide association study identifies multiple loci associated with both mammographic density and breast cancer riskQ35061252
A polygenic risk score for breast cancer in women receiving tamoxifen or raloxifene on NSABP P-1 and P-2.Q35082982
A locus on 19p13 modifies risk of breast cancer in BRCA1 mutation carriers and is associated with hormone receptor-negative breast cancer in the general populationQ35089479
Risk prediction of complex diseases from family history and known susceptibility loci, with applications for cancer screeningQ35136955
A common variant at the TERT-CLPTM1L locus is associated with estrogen receptor-negative breast cancerQ35755874
Genome-wide association analysis of more than 120,000 individuals identifies 15 new susceptibility loci for breast cancerQ35996692
The contributions of breast density and common genetic variation to breast cancer riskQ36137764
LDlink: a web-based application for exploring population-specific haplotype structure and linking correlated alleles of possible functional variantsQ36226921
Breast cancer risk prediction and individualised screening based on common genetic variation and breast density measurementQ36393193
A meta-analysis of genome-wide association studies of breast cancer identifies two novel susceptibility loci at 6q14 and 20q11.Q36435849
Prediction of breast cancer risk based on profiling with common genetic variantsQ36583004
Genome-wide association analysis identifies three new breast cancer susceptibility lociQ36842233
Multiple independent variants at the TERT locus are associated with telomere length and risks of breast and ovarian cancerQ36897003
Using the optimal receiver operating characteristic curve to design a predictive genetic test, exemplified with type 2 diabetesQ37149397
Use of tamoxifen and raloxifene for breast cancer chemoprevention in 2010Q37165630
Using clinical factors and mammographic breast density to estimate breast cancer risk: development and validation of a new predictive modelQ37172219
Value of adding single-nucleotide polymorphism genotypes to a breast cancer risk modelQ37246495
Newly discovered breast cancer susceptibility loci on 3p24 and 17q23.2.Q37356243
P275copyright licenseCreative Commons Attribution 4.0 InternationalQ20007257
P6216copyright statuscopyrightedQ50423863
P4510describes a project that usesBayes' theoremQ182505
P433issue1
P407language of work or nameEnglishQ1860
P304page(s)e0168601
P577publication date2017-01-20
P1433published inPLOS OneQ564954
P1476titleUsing Breast Cancer Risk Associated Polymorphisms to Identify Women for Breast Cancer Chemoprevention
P478volume12

Reverse relations

cites work (P2860)
Q87909686Breast Cancer Risk Model Requirements for Counseling, Prevention, and Screening
Q38613626Combining quantitative and qualitative breast density measures to assess breast cancer risk
Q92104850Copy number alterations associated with clinical features in an underrepresented population with breast cancer
Q64935691Is risk-stratified breast cancer screening economically efficient in Germany?
Q64240122Towards a more precise and individualized assessment of breast cancer risk

Search more.